Jolene, vaccine and cancer research — the enduring scientific legacy of Dolly Parton
Parton’s contributions have been eulogised after her death last week, and as a result, more people than ever know about her vast contributions provided specifically for the advancement of healthcare
Dolly Parton, the renowned singer, celebrity, and philanthropist who passed away at 80 after battling cancer, leaves behind an enduring legacy in science. Beyond her iconic status as Dolly, the cloned sheep, her contributions to healthcare have been widely acknowledged. Tedros Ghebreyesus, director-general of the World Health Organization, mourned her loss, praising her as an exceptional artist, champion of kindness, and ambassador of science and public health.
Her support for vaccine research is noteworthy. In March 2020, she donated $1 million to Vanderbilt Medical Centre to promote vaccine development. This funding was instrumental in the early stages of research into a messenger RNA vaccine produced by Moderna, which was later reported in The New England Journal of Medicine. Parton also contributed to the vaccine by posing for a photo while getting the injection and even modified the lyrics of her song Jolene to encourage vaccine uptake.
Parton's philanthropy extends beyond vaccine research. In 1994, she supported early HIV research by contributing to the charity compilation Red Hot + Country. More recently, she donated $1 million to Monroe Carell Jr. Children's Hospital at Vanderbilt for the pediatric cancer programme after her niece survived leukemia there. She followed this with another $1 million to advance research into pediatric infectious diseases.
In 2026, she released a new version of her song Light of a clear blue morning, with all proceeds going to pediatric cancer research at Monroe Carell and the renaming of East Tennessee Children's Hospital in her honour.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
